Pancreatic Cancer Research

ResearcherUniversity of Maryland, BaltimoreNo recent work listed

Ling Ma

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-2960-1956; OpenAlex author ID A5024084937. Sources: OpenAlex.

Their work

Papers
11 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2016: 2 papers · 2017: 1 paper · 2018: 2 papers · 2019: 3 papers · 2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper

Papers 11

  1. Clinical-radiomics nomogram using contrast-enhanced CT to predict histological grade and survival in pancreatic ductal adenocarcinoma. Co-author DOI 10.3389/fonc.2023.1218128↗
  2. Exosomal miR-485-3p derived from pancreatic ductal epithelial cells inhibits pancreatic cancer metastasis through targeting PAK1. Co-author DOI 10.1097/cm9.0000000000002154↗
  3. LncRNA H19-Derived miR-675-3p Promotes Epithelial-Mesenchymal Transition and Stemness in Human Pancreatic Cancer Cells by targeting the STAT3 Pathway. Co-author DOI 10.7150/jca.44833↗
  4. BRM transcriptionally regulates miR-302a-3p to target SOCS5/STAT3 signaling axis to potentiate pancreatic cancer metastasis. Co-author DOI 10.1016/j.canlet.2019.02.031↗
  5. Dasatinib can enhance paclitaxel and gemcitabine inhibitory activity in human pancreatic cancer cells. Co-author DOI 10.1080/15384047.2019.1579956↗
  6. Identification of differentially expressed genes in pancreatic ductal adenocarcinoma and normal pancreatic tissues based on microarray datasets. Co-author DOI 10.3892/mmr.2019.10414↗
  7. Long non-coding RNA MEG3 functions as a tumour suppressor and has prognostic predictive value in human pancreatic cancer. Co-author DOI 10.3892/or.2018.6178↗
  8. Long noncoding RNA H19 derived miR-675 regulates cell proliferation by down-regulating E2F-1 in human pancreatic ductal adenocarcinoma. Co-author DOI 10.7150/jca.21347↗
  9. BRM/SMARCA2 promotes the proliferation and chemoresistance of pancreatic cancer cells by targeting JAK2/STAT3 signaling. Co-author DOI 10.1016/j.canlet.2017.05.006↗
  10. The long noncoding RNA H19 promotes cell proliferation via E2F-1 in pancreatic ductal adenocarcinoma. Co-author DOI 10.1080/15384047.2016.1219814↗
  11. Hedgehog Signaling Regulates Epithelial-Mesenchymal Transition in Pancreatic Cancer Stem-Like Cells. First author DOI 10.7150/jca.13305↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Zhengkui Zhang · 8 shared papers, 2016–2022 · strength 0.70
  2. Yinmo Yang · 8 shared papers, 2016–2022 · strength 0.70
  3. Feng Wang · 7 shared papers, 2016–2022 · strength 0.58
  4. Xiaodong Tian · 6 shared papers, 2016–2022 · strength 0.56
  5. Marko Kornmann · 6 shared papers, 2016–2019 · strength 0.43
  6. Chong Du · 5 shared papers, 2016–2019 · strength 0.37
  7. Huahu Guo · 4 shared papers, 2017–2019 · strength 0.31
  8. Chunyuan Cen · 2 shared papers, 2019–2023 · strength 0.26
  9. Ping Han · 1 shared paper, 2023 · strength 0.17
  10. Linxia Wu · 1 shared paper, 2023 · strength 0.17
  11. Heshui Wu · 1 shared paper, 2023 · strength 0.17
  12. Chunyou Wang · 1 shared paper, 2023 · strength 0.17
  13. Mingzhe Li · 1 shared paper, 2022 · strength 0.16
  14. Jiayuh Lin · 1 shared paper, 2019 · strength 0.14
  15. Gloria Huei-Ting Su · 1 shared paper, 2019 · strength 0.14
  16. Xiaodong Tian · 2 shared papers, 2016–2018 · strength 0.14
  17. Xiaoran Liu · 2 shared papers, 2016–2017 · strength 0.13
  18. Long Rong · 1 shared paper, 2020 · strength 0.11
  19. Yongsu Ma · 1 shared paper, 2020 · strength 0.11
  20. Feng Wang · 1 shared paper, 2020 · strength 0.11
  21. Siqi Wang · 1 shared paper, 2019 · strength 0.09
  22. Ping Han · 1 shared paper, 2019 · strength 0.09
  23. Liying Liu · 1 shared paper, 2019 · strength 0.09
  24. Yazhou Wang · 1 shared paper, 2019 · strength 0.09

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.